Items where Author is "Schaefer, Niklas"

Group by: Item Type | No Grouping

Jump to: Article | Conference or Workshop Item | Other

Number of items: 28.

Article

Zeyen, Thomas and Boehm, Laura and Paech, Daniel and Schaefer, Niklas and Tzaridis, Theophilos and Duffy, Cathrina and Nitsch, Louisa and Schneider, Matthias and Potthoff, Anna-Laura and Schneider-Rothhaar, Javen Lennard and Steinbach, Joachim Peter and Hau, Peter and Kowalski, Thomas and Seidel, Clemens and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Zeiner, Pia Susan and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Glas, Martin and Gkika, Eleni and Vatter, Hartmut and Radbruch, Alexander and Herrlinger, Ulrich and Weller, Johannes and Schaub, Christina (2025) Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide. NEURO-ONCOLOGY, 27 (2). pp. 557-566. ISSN 1522-8517, 1523-5866

Schoenberger, Stefan and Mohseni, Mahsa Mir and Ellinger, Joerg and Tran, Giao Vu Quynh and Becker, Martina and Claviez, Alexander and Classen, Carl-Friedrich and Hermes, Barbara and Driever, Pablo Hernaiz and Jorch, Norbert and Lauten, Melchior and Mehlitz, Marcus and Schaefer, Niklas and Scheer-Preiss, Johanna and Schneider, Dominik T. and Troeger, Anja and Calaminus, Gabriele and Dilloo, Dagmar (2023) MicroRNA-profiling of miR-371 similar to 373-and miR-302/367-clusters in serum and cerebrospinal fluid identify patients with intracranial germ cell tumors. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 149 (2). pp. 791-802. ISSN 0171-5216, 1432-1335

Zeyen, Thomas and Paech, Daniel and Weller, Johannes and Schaefer, Niklas and Tzaridis, Theophilos and Duffy, Cathrina and Nitsch, Louisa and Schneider, Matthias and Potthoff, Anna-Laura and Steinbach, Joachim Peter and Hau, Peter and Schlegel, Uwe and Seidel, Clemens and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Zeiner, Pia Susan and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Glas, Martin and Radbruch, Alexander and Herrlinger, Ulrich and Schaub, Christina (2023) Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses. JOURNAL OF NEURO-ONCOLOGY, 164 (3). pp. 607-616. ISSN 0167-594X, 1573-7373

Tzaridis, Theophilos and Weller, Johannes and Bachurski, Daniel and Shakeri, Farhad and Schaub, Christina and Hau, Peter and Buness, Andreas and Schlegel, Uwe and Steinbach, Joachim-Peter and Seidel, Clemens and Goldbrunner, Roland and Schaefer, Niklas and Wechsler-Reya, Robert J. and Hallek, Michael and Scheffler, Bjoern and Glas, Martin and Haeberle, Lothar and Herrlinger, Ulrich and Coch, Christoph and Reiners, Katrin S. and Hartmann, Gunther (2023) A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression. INTERNATIONAL JOURNAL OF CANCER, 152 (2). pp. 308-319. ISSN 0020-7136, 1097-0215

Weller, Johannes and Zeyen, Thomas and Schaefer, Niklas and Schaub, Christina and Potthoff, Anna-Laura and Steinbach, Joachim P. and Hau, Peter and Seidel, Clemens and Goldbrunner, Roland and Tabatabai, Ghazaleh and Vatter, Hartmut and Tzaridis, Theophilos and Schneider, Matthias and Herrlinger, Ulrich (2023) The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial. JOURNAL OF NEURO-ONCOLOGY, 164 (3). pp. 749-755. ISSN 0167-594X, 1573-7373

Weller, Johannes and Schaefer, Niklas and Schaub, Christina and Potthoff, Anna-Laura and Steinbach, Joachim P. and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Seidel, Clemens and Krex, Dietmar and Goldbrunner, Roland and Pietsch, Torsten and Tzaridis, Theophilos and Zeyen, Thomas and Borger, Valeri and Guresir, Erdem and Vatter, Hartmut and Herrlinger, Ulrich and Schneider, Matthias (2022) Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS. JOURNAL OF NEURO-ONCOLOGY, 159 (1). pp. 95-101. ISSN 0167-594X, 1573-7373

Le Rhun, Emilie and Devos, Patrick and Winklhofer, Sebastian and Lmalen, Hafida and Brandsma, Dieta and Kumthekar, Priya and Castellano, Antonella and Compter, Annette and Dhermain, Frederic and Franceschi, Enrico and Forsyth, Peter and Furtner, Julia and Galldiks, Norbert and Perez-Larraya, Jaime Gallego and Gempt, Jens and Hattingen, Elke and Hempel, Johann Martin and Lukacova, Slavka and Minniti, Giuseppe and O'Brien, Barbara and Postma, Tjeerd J. and Roth, Patrick and Ruda, Roberta and Schaefer, Niklas and Schmidt, Nils O. and Snijders, Tom J. and Thust, Steffi and van den Bent, Martin and van der Hoorn, Anouk and Vogin, Guillaume and Smits, Marion and Tonn, Joerg C. and Jaeckle, Kurt and Preusser, Matthias and Glantz, Michael and Wen, Patrick Y. and Bendzsus, Martin and Weller, Michael (2022) Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. NEURO-ONCOLOGY, 24 (10). pp. 1726-1735. ISSN 1522-8517, 1523-5866

Schaefer, Niklas and Bumes, Elisabeth and Eberle, Fabian and Fox, Viola and Gessler, Florian and Giordano, Frank A. and Konczalla, Juergen and Onken, Julia and Ottenhausen, Malte and Scherer, Moritz and Schneider, Matthias and Vatter, Hartmut and Herrlinger, Ulrich and Schuss, Patrick (2021) Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey. JOURNAL OF NEURO-ONCOLOGY, 153 (3). pp. 479-485. ISSN 0167-594X, 1573-7373

Tzaridis, Theophilos and Schaefer, Niklas and Weller, Johannes and Steinbach, Joachim-Peter and Schlegel, Uwe and Seidel, Sabine and Sabel, Michael and Hau, Peter and Seidel, Clemens and Krex, Dietmar and Goldbrunner, Roland and Tonn, Joerg-Christian and Grauer, Oliver and Kebir, Sied and Schneider, Matthias and Schaub, Christina and Vatter, Hartmut and Coch, Christoph and Glas, Martin and Fimmers, Rolf and Pietsch, Torsten and Reifenberger, Guido and Herrlinger, Ulrich and Felsberg, Joerg (2021) MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial. INTERNATIONAL JOURNAL OF CANCER, 148 (7). pp. 1695-1707. ISSN 0020-7136, 1097-0215

Kebir, Sied and Schaub, Christina and Junold, Nina and Hattingen, Elke and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Galldiks, Norbert and Weller, Johannes and Mack, Frederic and Tzaridis, Theophilos and Baehr, Oliver and Seidel, Clemens and Schlegel, Uwe and Schmidt-Graf, Friederike and Rohde, Veit and Borchers, Christian and Tabatabai, Ghazaleh and Haenel, Mathias and Sabel, Michael and Gerlach, Ruediger and Krex, Dietmar and Belka, Claus and Vatter, Hartmut and Proescholdt, Martin and Glas, Martin and Herrlinger, Ulrich (2019) Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial. JOURNAL OF NEURO-ONCOLOGY, 144 (3). pp. 501-509. ISSN 0167-594X, 1573-7373

Weller, Johannes and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Brehmer, Stefanie and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Kebir, Sied and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. LANCET ONCOLOGY, 20 (10). pp. 1444-1453. ISSN 1470-2045, 1474-5488

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortmann, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Kowalski, Thomas and Ringel, Florian and Schmidt-Graf, Friederike and Suchorska, Bogdana and Brehmer, Stefanie and Weyerbrock, Astrid and Renovanz, Miriam and Bullinger, Lars and Galldiks, Norbert and Vajkoczy, Peter and Misch, Martin and Vatter, Hartmut and Stuplich, Moritz and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Schaub, Christina and Stummer, Walter and Tonn, Joerg-Christian and Simon, Matthias and Keil, Vera C. and Nelles, Michael and Urbach, Horst and Coenen, Martin and Wick, Wolfgang and Weller, Michael and Fimmers, Rolf and Schmid, Matthias and Hattingen, Elke and Pietsch, Torsten and Coch, Christoph and Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. LANCET, 393 (10172). pp. 678-688. ISSN 0140-6736, 1474-547X

Schaefer, Niklas and Proescholdt, Martin and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Grauer, Oliver and Goldbrunner, Roland and Friedrich, Franziska and Rohde, veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Grau, Stefan and Haenel, Mathias and Schnell, Oliver and Krex, Dietmar and Vajkoczy, Peter and Tabatabai, Ghazaleh and Mack, Frederic and Schaub, Christina and Tzaridis, Theophilos and Niessen, Michael and Kebir, Sied and Leutgeb, Barbara and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin and Herrlinger, Ulrich (2018) Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. NEURO-ONCOLOGY, 20 (7). pp. 975-985. ISSN 1522-8517, 1523-5866

Schaub, Christina and Kebir, Sied and Junold, Nina and Hattingen, Elke and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Niessen, Michael and Mack, Frederic and Stuplich, Moritz and Tzaridis, Theophilos and Baehr, Oliver and Kortmann, Rolf-Dieter and Schlegel, Uwe and Schmidt-Graf, Friederike and Rohde, Veit and Braun, Christian and Haenel, Mathias and Sabel, Michael and Gerlach, Ruediger and Krex, Dietmar and Belka, Claus and Vatter, Hartmut and Proescholdt, Martin and Herrlinger, Ulrich and Glas, Martin (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 144 (8). pp. 1581-1589. ISSN 0171-5216, 1432-1335

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Maciaczyk, Jaroslaw and Grau, Stefan and Schnell, Oliver and Haenel, Mathias and Krex, Dietmar and Vajkoczy, Peter and Gerlach, Ruediger and Kortmann, Rolf-Dieter and Mehdorn, Maximilian and Tuettenberg, Jochen and Mayer-Steinacker, Regine and Fietkau, Rainer and Brehmer, Stefanie and Mack, Frederic and Stuplich, Moritz and Kebir, Sied and Kohnen, Ralf and Dunkl, Elmar and Leutgeb, Barbara and Proescholdt, Martin and Pietsch, Torsten and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. JOURNAL OF CLINICAL ONCOLOGY, 34 (14). 1611-U134. ISSN 0732-183X, 1527-7755

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): LBA2000. ISSN 0732-183X, 1527-7755

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (18supp): LBA2000. ISSN 0732-183X, 1527-7755

Reutter, Heiko and Becker, Tim and Ludwig, Michael and Schaefer, Niklas and Detlefsen, Birte and Beaudoin, Sylvie and Fisch, Margit and Ebert, Anne-Karoline and Roesch, Wolfgang and Noethen, Markus M. and Boemers, Thomas M. and Betz, Regina C. (2006) Family-based association study of the MTHFR polymorphism C677T in the bladder-exstrophy-epispadias-complex. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 140A (22). pp. 2506-2509. ISSN 1552-4825

Conference or Workshop Item

Weller, Johannes and Zeyen, Thomas and Schlegel, Uwe and Lazaridis, Lazaros and Werner, Jan-Michael and Onken, Julia and Zeiner, Pia and Drexler, Richard and Hau, Peter and Seidel, Clemens and Grosse, Lucia and Clusmann, Hans and Sabel, Michael and Ringel, Florian and Pichler, Josef and Grauer, Oliver and Hundsberger, Thomas and Schnell, Oliver and Mair, Maximilian J. and Uhl, Martin and Schmidt-Graf, Friederike and Glas, Martin and Galldiks, Norbert and Unteroberdoerster, Meike and Steinbach, Joachim and Ricklefs, Franz and Renovanz, Mirjam and Delev, Daniel Ivanov and Turgut, Merih O. and Flesch, Oliver R. and Cipriani, Debora and Preusser, Matthias and Kebir, Sied and Misch, Martin and Goldbrunner, Roland and Westphal, Manfred and Tabatabai, Ghazaleh and Schaefer, Niklas and Schneider, Matthias and Vatter, Hartmut and Giordano, Frank and Schaub, Christina and Herrlinger, Ulrich (2022) CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT. In: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 16-20, 2022, Tampa Bay, FL.

Zeyen, Thomas and Paech, Daniel and Weller, Johannes and Schaefer, Niklas and Tzaridis, Theophilos and Duffy, Cathrina and Nitsch, Louisa and Schneider, Matthias and Steinbach, Joachim and Hau, Peter and Schlegel, Uwe and Seidel, Clemens and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Zeiner, Pia and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Glas, Martin and Radbruch, Alexander and Herrlinger, Ulrich and Schaub, Christina (2022) NIMG-32. POSTPROGRESSION SURVIVAL AND MRI FEATURES AT PROGRESSION IN MGMT-METHYLATED GLIOBLASTOMA FOLLOWING TEMOZOLOMIDE (TMZ) OR CCNU/TMZ THERAPY - AN ANALYSIS OF THE CETEG/NOA-09-TRIAL. In: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 16-20, 2022, Tampa Bay, FL.

Le Rhun, Emilie and Devos, Patrick and Winklhofer, Sebastian and Lmalem, Hafida and Brandsma, Dieta and Gallego Perez-Larraya, Jaime and Castellano, Antonella and Compter, Annette and Dhermain, Frederic and Franceschi, Enrico and Forsyth, Peter and Furtner, Julia and Galldiks, Norbert and Gempt, Jens and Glantz, Michael and Hattingen, Elke and Hempel, Johann Martin and Jaeckle, Kurt and Kumthekar, Priya and Lukacova, Slavka and Minniti, Giuseppe and O'Brien, Barbara and Postma, Tjeerd J. and Roth, Patrick and Ruda, Roberta and Schaefer, Niklas and Schmidt, Nils Ole and Smits, Marion and Snijders, Tom and Thust, Steffi and Tonn, Joerg-Christian and van den Bent, Martin and van den Hoorn, Anouk and Vogin, Guillaume and Preusser, Matthias and Wen, Patrick and Bendszus, Martin and Weller, Michael (2021) INTEROBSERVER VARIABILITY OF THE REVISED IMAGING SCORECARD FOR LEPTOMENINGEAL METASTASIS: A JOINT EORTC BRAIN TUMOR GROUP AND RANO EFFORT. In: 26th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 18-21, 2021, Boston, MA.

Tzaridis, Theophilos and Weller, Johannes and Bachurski, Daniel and Shakheri, Farhad and Schaub, Christina and Hau, Peter and Buness, Andreas and Schlegel, Uwe and Steinbach, Joachim and Seidel, Clemens and Goldbrunner, Roland and Schaefer, Niklas and Wechsler-Reya, Robert and Scheffler, Bjoern and Glas, Martin and Haeberle, Lothar and Herrlinger, Ulrich and Coch, Christoph and Reiners, Katrin and Hartmann, Gunther (2021) PROTEIN SURFACE SIGNATURE ON SERUM EXTRACELLULAR VESICLES FOR NON-INVASIVE DETECTION OF TUMOR PROGRESSION IN GLIOBLASTOMA PATIENTS. In: 26th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 18-21, 2021, Boston, MA.

Other

Tzaridis, Theophilos and Schaefer, Niklas and Weller, Johannes and Steinbach, Joachim and Seidel, Sabine and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Seidel, Clemens and Krex, Dietmar and Goldbrunner, Roland and Tonn, Joerg-Christian and Grauer, Oliver and Schaub, Christina and Coch, Christoph and Glas, Martin and Pietsch, Torsten and Fimmers, Rolf and Reifenberger, Guido and Felsberg, Joerg and Herrlinger, Ulrich (2019) MGMT PROMOTER METHYLATION ANALYSIS FOR ALLOCATING COMBINED CCNU/TMZ CHEMOTHERAPY: LESSONS LEARNED FROM THE CeTeG/NOA-09 TRIAL. OXFORD UNIV PRESS INC, CARY.

Weller, Johannes and Tzaridis, Theophilos and Steinbach, Joachim and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Matthias, Schmid and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2018) QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortman, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Tabatabai, Ghazaleh and Ringel, Florian and Schmidt-Graf, Friederike and Brehmer, Stefanie and Weyerbrock, Astrid and Bullinger, Lars and Vajkoczy, Peter and Vatter, Hartmut and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Stummer, Walter and Simon, Matthias and Keil, Vera and Nelles, Michael and Fimmers, Rolf and Pietsch, Torsten and Hattingen, Elke and Coch, Christoph and Glas, Martin (2017) PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. OXFORD UNIV PRESS INC, CARY.

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Kohnen, Ralf and Urbach, Horst and Stummer, Walter and Glas, Martin (2014) QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS. OXFORD UNIV PRESS INC, CARY.

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim and Weyerbrock, Anja and Hau, Peter and Goldbrunner, Roland and Kohnen, Ralf and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) BEVACIZUMAB, IRINOTECAN AND RADIOTHERAPY VERSUS STANDARD TEMOZOLOMIDE AND RADIOTHERAPY IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: UPDATED RESULTS FROM THE RANDOMIZED MULTICENTER GLARIUS TRIAL. OXFORD UNIV PRESS INC, CARY.

This list was generated on Sun Mar 22 11:22:18 2026 CET.

Export as	Atom RSS 1.0 RSS 2.0